Prostate cancer-induced immunodysfunction: A lesson from organ cultures [4]

Immunology Letters

Volumn 100, Issue 1, 2005, Pages 98-102

  Kasic, Tihana ^a   Viola, Antonella ^b  

^a VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CANCER VACCINE; CISPLATIN; DOXORUBICIN; HORMONE;

CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; DRUG EFFECT; HUMAN; IMMUNE DEFICIENCY; LETTER; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER;

ANIMALS; HUMANS; MALE; ORGAN CULTURE TECHNIQUES; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 24344466373     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2005.06.021     Document Type: Letter

References (32)

1. O.J. Finn Cancer vaccines: between the idea and the reality Nat Rev Immunol 3 2003 630 641
2. P. Van Der Bruggen, Y. Zhang, P. Chaux, V. Stroobant, C. Panichelli, E.S. Schultz, J. Chapiro, B.J. Van Den Eynde, F. Brasseur, and T. Boon Tumor-specific shared antigenic peptides recognized by human T cells Immunol Rev 188 2002 51 64
3. S.A. Rosenberg, Y.C. Yang, and N.P. Restifo Cancer immunotherapy: moving beyond current vaccines Nat Med 10 2004 909 915
4. J.M. Timmerman, and R. Levy Dendritic cell vaccines for cancer immunotherapy Annu Rev Med 50 1999 507 529
5. P.A. Lodge, L.A. Jones, R.A. Bader, G.P. Murphy, and M.L. Salgaller Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a phase II clinical trial Cancer Res 60 2000 829 833
6. N. Meidenbauer, D.T. Harris, L.E. Spitler, and T.L. Whiteside Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer Prostate 43 2000 88 100
7. S.K. Nair, A. Heiser, D. Boczkowski, A. Majumdar, M. Naoe, J.S. Lebkowski, J. Vieweg, and E. Gilboa Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells Nat Med 6 2003 1011 1017
8. P.G. Coulie, and P. Van der Bruggen T-cell responses of vaccinated cancer patients Curr Opin Immunol 15 2003 131 137
9. G. Parmiani, C. Castelli, P. Dalerba, R. Mortarini, L. Rivoltini, F.M. Marincola, and A. Anichini Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going? J Natl Cancer Inst 94 2002 805 818
10. F.M. Marincola, E.M. Jaffee, D.J. Hicklin, and S. Ferrone Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance Adv Immunol 74 2000 181 273
11. T.L. Whiteside Signaling defects in T lymphocytes of patients with malignancy Cancer Immunol Immunother 48 1999 346 352
12. A.E. Freeman, and R.M. Hoffman In vivo-like growth of human tumors in vitro Proc Natl Acad Sci USA 83 1986 2694 2698
13. T.G. Pretlow, B. Yang, and T.P. Pretlow Organ culture of benign, aging, and hyperplastic human prostate Microsc Res Tech 30 1995 271 281
14. K.C. O'Connor Three-dimensional cultures of prostatic cells: tissue models for the development of novel anti-cancer therapies Pharm Res 16 1999 486 493
15. J. Varani, M.K. Dame, K. Wojno, L. Schuger, and K.J. Johnson Characteristic of nonmalignant and malignant human prostate in organ culture Lab Invest 79 1999 723 731
16. V. Bronte, T. Kasic, G. Gri, K. Gallana, G. Borsellino, L. Battistini, M. Iafrate, T. Prayer-Galetti, F. Pagano, and V. Viola Boosting anti-tumor responses of T lymphocytes infiltrating human prostate cancers J Exp Med 201 8 2005 1257 1268
17. A. Keskinege, S. Elgun, and E. Yilmaz Possible implications of arginase and diamine oxidase in prostatic carcinoma Cancer Detect Prev 25 2001 76 79
18. S.H. Aaltoma, P.K. Lipponen, and V.M. Kosma Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer Anticancer Res 21 2001 3101 3106
19. J. Wang, M. Torbenson, Q. Wang, J.Y. Ro, and M. Becich Expression of inducible nitric oxide synthase in paired neoplastic and non-neoplastic primary prostate cell cultures and prostatectomy specimen Urol Oncol 21 2003 117 122
20. W. Xu, L.Z. Liu, M. Loizidou, M. Ahmed, and I.G. Charles The role of nitric oxide in cancer Cell Res 12 2002 311 320
21. D.C. Jenkins, I.G. Charles, L.L. Thomsen, D.W. Moss, L.S. Holmes, S.A. Baylis, P. Rhodes, K. Westmore, P.C. Emson, and S. Moncada Roles of nitric oxide in tumor growth Proc Natl Acad Sci USA 92 1995 4392 4396
22. W. Xu, L. Liu, G.C. Smith, and G. Charles Nitric oxide upregulates expression of DNA-PKcs to protect cells from DNA-damaging anti-tumour agents Nat Cell Biol 2 2000 339 345
23. S.D. Cederbaum, H. Yu, W.W. Grody, R.M. Kern, P. Yoo, and R.K. Iyer Arginases I and II: do their functions overlap? Mol Genet Metab 81 2004 S38 S44
24. C.I. Chang, J.C. Liao, and L. Kuo Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity Cancer Res 61 2001 1100 1106
25. G. Wu, and S.M. Morris Jr. Arginine metabolism: nitric oxide and beyond Biochem J 336 1998 1 17
26. V. Bronte, P. Serafini, A. Mazzoni, D.M. Segal, and P. Zanovello l-arginine metabolism in myeloid cells controls T-lymphocyte functions Trends Immunol 24 2003 302 306
27. N. Moulian, F. Truffault, Y.M. Gaudry-Talarmain, A. Serraf, and S. Berrih-Aknin In vivo and in vitro apoptosis of human thymocytes are associated with nitrotyrosine formation Blood 97 2001 3521 3530
28. C. Brito, M. Naviliat, A.C. Tiscornia, F. Vuillier, G. Gualco, G. Dighiero, R. Radi, and A.M. Cayota Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death J Immunol 162 1999 3356 3366
29. A.H. Zea, P.C. Rodriguez, M.B. Atkins, C. Hernandez, S. Signoretti, J. Zabaleta, D. McDermott, D. Quiceno, A. Youmans, A. O'Neill, J. Mier, and A.C. Ochoa Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion Cancer Res 65 2005 3044 3048
30. S. Kusmartsev, and D.I. Gabrilovich STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion J Immunol 174 2005 4880 4891
31. C. De Santo, P. Serafini, I. Marigo, L. Dolcetti, M. Bolla, P. Del Soldato, C. Melani, C. Guiducci, M.P. Colombo, M. Iezzi, P. Musiani, P. Zanovello, and V. Bronte Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination Proc Natl Acad Sci USA 102 2005 4185 4190
32. V. Bronte, P. Serafini, C. De Santo, I. Marigo, V. Tosello, A. Mazzoni, D.M. Segal, C. Staib, M. Lowel, G. Sutter, M.P. Colombo, and P. Zanovello IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice J Immunol 170 2003 270 278